Phase 2 Study of Mitoxantrone, Etoposide, and Cytarabine (MEC) plus Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

IRB/UVA Tracking #
20450
Contact
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Michael Keng
Status
OPEN TO ACCRUAL